Tapering versus abrupt cessation The clinical trials did not specifically study tapering protocols, but physiological principles suggest a gradual dose reduction may produce a smoother transition than abrupt cessation
Background: How GLP-1s evolved from diabetes treatment to anti-obesity medications Glucagon-like peptide-1 receptor agonists (GLP-1s) have a notable history in medical treatment, beginning as therapies for type 2 diabetes and later emerging as highly effective agents for weight loss
At Set Point Medical Weight Loss Clinic, our expert medical team is always available to discuss your treatment options and guide you towards the best health solutions
It has had very good weight loss, around 27% of total body mass, but the drop-out rate in the trial is 20% due to side effects, he says
She also holds a BA in Sociology from UCLA, graduating Summa Cum Laude
Among injectable options, liraglutide is less expensive than other GLP-1 medications, as a generic version is available
